Literature DB >> 18325017

Status epilepticus: clinical presentation, cause, outcome, and predictors of death in 119 Ethiopian patients.

Amanuel Amare1, Guta Zenebe, Julie Hammack, Gail Davey.   

Abstract

PURPOSE: Status epilepticus (SE) is a common neurological emergency with high morbidity and mortality. There is no study that has been conducted among Ethiopian patients with SE. The purpose of this study was to analyze clinical presentation, causes, complications, outcomes, and predictors of mortality.
METHODS: In this retrospective study, patients aged >or=13 year with SE were included. Medical records were reviewed and demographic and clinical data were collected.
RESULTS: Records of 119 patients were analyzed; preexisting epilepsy was found in 38.7%. Primarily generalized and focal with secondarily generalized (FWSG) seizures were identified in 60.5% and 36%, respectively. Simple partial SE occurred in 3.4%. Central nervous system (CNS) infection was the most common cause of SE in the whole group as well as in those with new onset seizure. Antiepileptic drug withdrawal (AEDW) was the main cause in those with preexisting seizure. One or more complications were detected in 61%. Intravenous diazepam and oral phenytoin were given to 95% and 97.5%, respectively. Case fatality was 20.2%; poor outcome occurred in 24%. Predictors of mortality were FWSG type, acute symptomatic etiology, stroke, systemic infection, and HIV/AIDS and its CNS complications. Idiopathic and SE due to AEDW were associated with good prognosis.
CONCLUSIONS: CNS infection was the most common cause of SE in the whole group and AEDW was the major cause in patients with preexisting epilepsy. Parenteral anticonvulsants, emergency measurement of serum AED level, and electroencephalography for urgent diagnosis and monitoring were unavailable. Mortality was related to underlying etiologies especially HIV/AIDS and its CNS complications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18325017     DOI: 10.1111/j.1528-1167.2008.01556.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  19 in total

Review 1.  Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application.

Authors:  Annamaria Vezzani; Raymond Dingledine; Andrea O Rossetti
Journal:  Expert Rev Neurother       Date:  2015       Impact factor: 4.618

2.  Status epilepticus of inflammatory etiology: a cohort study.

Authors:  Marianna Spatola; Jan Novy; Renaud Du Pasquier; Josep Dalmau; Andrea O Rossetti
Journal:  Neurology       Date:  2015-06-19       Impact factor: 9.910

Review 3.  Why won't it stop? The dynamics of benzodiazepine resistance in status epilepticus.

Authors:  Richard J Burman; Richard E Rosch; Jo M Wilmshurst; Arjune Sen; Georgia Ramantani; Colin J Akerman; Joseph V Raimondo
Journal:  Nat Rev Neurol       Date:  2022-05-10       Impact factor: 44.711

4.  Human Immunodeficiency Viral Infection and Status Epilepticus in United States (2002-2009).

Authors:  Saqib A Chaudhry; Mohammad Rauf Afzal; Gustavo J Rodriguez; Shahram Majidi; Scott Bundlie; Ameer E Hassan; M Fareed K Suri; Adnan I Qureshi
Journal:  J Vasc Interv Neurol       Date:  2015-07

5.  A clinical, radiological and outcome study of status epilepticus from India.

Authors:  J Kalita; P P Nair; Usha Kant Misra
Journal:  J Neurol       Date:  2010-02       Impact factor: 4.849

6.  Contributing towards the betterment of translational epilepsy research in Africa: needs, challenges, resources, and opportunities.

Authors:  Yohannes W Woldeamanuel; Belaineh Girma
Journal:  Curr Neurol Neurosci Rep       Date:  2014-08       Impact factor: 5.081

Review 7.  Systemic Complications Following Status Epilepticus.

Authors:  Maximiliano A Hawkes; Sara E Hocker
Journal:  Curr Neurol Neurosci Rep       Date:  2018-02-07       Impact factor: 5.081

8.  Mortality trends from 2003 to 2009 among adolescents and young adults in rural Western Kenya using a health and demographic surveillance system.

Authors:  Penelope A Phillips-Howard; Frank O Odhiambo; Mary Hamel; Kubaje Adazu; Marta Ackers; Anne M van Eijk; Vincent Orimba; Anja van't Hoog; Caryl Beynon; John Vulule; Mark A Bellis; Laurence Slutsker; Kevin deCock; Robert Breiman; Kayla F Laserson
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

9.  Practice parameters in management of status epileptics.

Authors:  Usha Kant Misra; Jayantee Kalita; Sanjeev Kumar Bhoi
Journal:  Ann Indian Acad Neurol       Date:  2014-03       Impact factor: 1.383

Review 10.  Dysphagia as a risk factor for mortality in Niemann-Pick disease type C: systematic literature review and evidence from studies with miglustat.

Authors:  Mark Walterfang; Yin-Hsiu Chien; Jackie Imrie; Derren Rushton; Danielle Schubiger; Marc C Patterson
Journal:  Orphanet J Rare Dis       Date:  2012-10-06       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.